143 related articles for article (PubMed ID: 29862309)
1. Erythropoietin enhances migration of human neuroblastoma cells: in vitro studies and potential therapeutic implications.
Poniewierska-Baran A; Rajewska-Majchrzak J; Ratajczak MZ
J Cancer Stem Cell Res; 2017; 5():. PubMed ID: 29862309
[TBL] [Abstract][Full Text] [Related]
2. Human rhabdomyosarcoma cells express functional erythropoietin receptor: Potential therapeutic implications.
Poniewierska-Baran A; Suszynska M; Sun W; Abdelbaset-Ismail A; Schneider G; Barr FG; Ratajczak MZ
Int J Oncol; 2015 Nov; 47(5):1989-97. PubMed ID: 26412593
[TBL] [Abstract][Full Text] [Related]
3. Expression of erythropoietin and its receptor in neuroblastomas.
Sartelet H; Fabre M; Castaing M; Bosq J; Racu I; Lagonotte E; Scott V; Lecluse Y; Barette S; Michiels S; Vassal G
Cancer; 2007 Sep; 110(5):1096-106. PubMed ID: 17647284
[TBL] [Abstract][Full Text] [Related]
4. No erythropoietin-induced growth is observed in non-small cell lung cancer cells.
Frille A; Leithner K; Olschewski A; Olschewski H; Wohlkönig C; Hrzenjak A
Int J Oncol; 2018 Feb; 52(2):518-526. PubMed ID: 29345289
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin/erythropoietin receptor system is involved in angiogenesis in human neuroblastoma.
Ribatti D; Poliani PL; Longo V; Mangieri D; Nico B; Vacca A
Histopathology; 2007 Apr; 50(5):636-41. PubMed ID: 17394500
[TBL] [Abstract][Full Text] [Related]
6. The tumor promoting roles of erythropoietin/erythropoietin receptor signaling pathway in gastric cancer.
Hu W; Zhang Y; Jiang Z; Wang L; Li J; Chen S; Dai N; Si J
Tumour Biol; 2016 Aug; 37(8):11523-33. PubMed ID: 27086036
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin Signaling in the Microenvironment of Tumors and Healthy Tissues.
Liu W; Varier KM; Sample KM; Zacksenhaus E; Gajendran B; Ben-David Y
Adv Exp Med Biol; 2020; 1223():17-30. PubMed ID: 32030683
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts.
Tankiewicz-Kwedlo A; Hermanowicz J; Surażynski A; Rożkiewicz D; Pryczynicz A; Domaniewski T; Pawlak K; Kemona A; Pawlak D
Mol Cell Biochem; 2016 Oct; 421(1-2):1-18. PubMed ID: 27543111
[TBL] [Abstract][Full Text] [Related]
9. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
[TBL] [Abstract][Full Text] [Related]
10. A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells.
Um M; Gross AW; Lodish HF
Cell Signal; 2007 Mar; 19(3):634-45. PubMed ID: 17045782
[TBL] [Abstract][Full Text] [Related]
11. Targeted near-infrared imaging of the erythropoietin receptor in human lung cancer xenografts.
Doleschel D; Mundigl O; Wessner A; Gremse F; Bachmann J; Rodriguez A; Klingmüller U; Jarsch M; Kiessling F; Lederle W
J Nucl Med; 2012 Feb; 53(2):304-11. PubMed ID: 22228796
[TBL] [Abstract][Full Text] [Related]
12. Co-stimulation with stem cell factor and erythropoietin enhances migration of c-Kit expressing cervical cancer cells through the sustained activation of ERK1/2.
Aguilar C; Aguilar C; Lopez-Marure R; Jiménez-Sánchez A; Rocha-Zavaleta L
Mol Med Rep; 2014 May; 9(5):1895-902. PubMed ID: 24626629
[TBL] [Abstract][Full Text] [Related]
13. Lineage-restricted recruitment of immature hematopoietic progenitor cells in response to Epo after normal hematopoietic cell transfection with EpoR.
McArthur GA; Longmore GD; Klingler K; Johnson GR
Exp Hematol; 1995 Jul; 23(7):645-54. PubMed ID: 7601257
[TBL] [Abstract][Full Text] [Related]
14. Response to erythropoietin in erythroid subclones of the factor-dependent cell line 32D is determined by translocation of the erythropoietin receptor to the cell surface.
Migliaccio AR; Migliaccio G; D'Andrea A; Baiocchi M; Crotta S; Nicolis S; Ottolenghi S; Adamson JW
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11086-90. PubMed ID: 1722318
[TBL] [Abstract][Full Text] [Related]
15. Far-western blotting as a solution to the non-specificity of the anti-erythropoietin receptor antibody.
Fecková B; Kimáková P; Ilkovičová L; Szentpéteriová E; Debeljak N; Solárová Z; Sačková V; Šemeláková M; Bhide M; Solár P
Oncol Lett; 2016 Aug; 12(2):1575-1580. PubMed ID: 27446474
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin-dependent autocrine secretion of tumor necrosis factor-alpha in hematopoietic cells modulates proliferation via MAP kinase--ERK-1/2 and does not require tyrosine docking sites in the EPO receptor.
Chen J; Jacobs-Helber SM; Barber DL; Sawyer ST
Exp Cell Res; 2004 Aug; 298(1):155-66. PubMed ID: 15242770
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin biology in cancer.
Hardee ME; Arcasoy MO; Blackwell KL; Kirkpatrick JP; Dewhirst MW
Clin Cancer Res; 2006 Jan; 12(2):332-9. PubMed ID: 16428469
[TBL] [Abstract][Full Text] [Related]
18. Role of Erythropoietin in Cerebral Glioma: An Innovative Target in Neuro-Oncology.
Torregrossa F; Aguennouz M; La Torre D; Sfacteria A; Grasso G
World Neurosurg; 2019 Nov; 131():346-355. PubMed ID: 31658577
[TBL] [Abstract][Full Text] [Related]
19. Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis.
Rainville N; Jachimowicz E; Wojchowski DM
Expert Opin Ther Targets; 2016; 20(3):287-301. PubMed ID: 26419263
[TBL] [Abstract][Full Text] [Related]
20. The role of erythropoietin and erythropoietin receptor in malignant laryngeal tumors.
Vukelic J; Dobrila-Dintinjana R; Jonjic N; Dekanic A; Ilijic V
Med Hypotheses; 2013 Dec; 81(6):1155-8. PubMed ID: 24134826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
